Clot Management Devices Market Research, 2033
The global clot management devices market size was valued at $1.9 billion in 2023, and is projected to reach $3.2 billion by 2033, growing at a CAGR of 5.2% from 2024 to 2033. The growth of the clot management devices market is driven by several key factors, including the rising incidence of cardiovascular diseases and venous thromboembolism, which are leading causes of morbidity and mortality worldwide. Advancements in minimally invasive procedures, coupled with increasing patient awareness and preference for initial treatment, are also contributing to market expansion. In addition, the growing geriatric population, which is more susceptible to clotting disorders, and the development of innovative devices with enhanced safety and efficacy are further fueling market growth. Clot management devices are medical tools designed to treat and remove blood clots from the vascular system, primarily used to manage conditions such as deep vein thrombosis (DVT) , pulmonary embolism (PE) , and arterial thrombosis. These devices include thrombectomy devices, which mechanically extract clots, and thrombolytic infusion catheters, which deliver clot-dissolving drugs directly to the site of the blockage. Clot management devices are crucial in restoring normal blood flow, preventing complications such as stroke or organ damage, and reducing the risk of mortality in patients with thromboembolic disorders. Their application extends to both emergency settings and planned interventions, where quick and effective clot removal is essential for patient recovery. These devices are also increasingly used in minimally invasive procedures, offering safer alternatives to traditional surgical methods.
Key Takeaways
- The Clot Management Devices market share study covers 20 countries. The research includes a segment analysis of each country in terms of value for the projected period.
- More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major Clot Management Devices industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
- The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and assist stakeholders in making educated decisions to achieve their most ambitious growth objectives.
Key Market Dynamics
According to clot management devices market forecast analysis the key factors driving the growth of the market are rise in prevalence of cardiovascular diseases, growing geriatric population, rise in the research and development in the clot management devices. The rise in the prevalence of cardiovascular diseases is a significant driver for the clot management devices market, as these conditions often lead to the formation of blood clots, which can result in life-threatening events such as strokes, pulmonary embolisms, and deep vein thrombosis. According to a 2023 article by Stroke Awareness Foundation, in U.S. about 795, 000 people suffer a stroke each year. With an aging global population and the increasing prevalence of risk factors such as obesity, diabetes, and hypertension, the incidence of cardiovascular diseases is on the rise. This growing burden has led to a greater demand for effective clot management solutions, driving innovation and advancements in medical devices designed to prevent, detect, and treat blood clots. Thus, the rise in prevalence of cardiovascular diseases, growing geriatric population is expected to drive the clot management devices market growth.
In addition, the rising awareness among healthcare providers and patients about the importance of timely clot management, coupled with advancements in minimally invasive procedures, has further fueled the adoption of these clot management devices. Thus, the rise in adoption of the minimally invasive surgical procedure and technological advancement in the clot management devices is expected to drive the clot management devices market growth.
Deaths from cardiovascular diseases, 1990-2021
The increase in deaths from cardiovascular disease, from 12, 345, 727 in 1990 to 19, 906, 615 in 2021, represents a significant rise in the prevalence of cardiovascular conditions over the past three decades. This surge reflects broader trends such as aging populations, lifestyle changes leading to higher rates of risk factors like obesity and diabetes, and improved diagnostic capabilities that identify more cases. Consequently, this upward trend in cardiovascular mortality is expected to drive substantial growth in the clot management devices market size
Market Segmentation
The clot management devices market is segmented into product, end user, and region. By product, the market is classified into neurovascular embolectomy devices, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis (CDT) devices, inferior vena cava filters (IVCF) . By end user, it is segregated into diagnostic centers and hospitals. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Regional/Country Market Outlook
North America dominated the clot management devices market share in 2023 owing to substantial research and development activities, a strong presence of major key players, well-established healthcare infrastructure, and surge in prevalence of cardiovascular disease. According to clot management devices market opportunity analysis, In the Asia-Pacific region, rapid market expansion is anticipated due to improving healthcare infrastructure, rise in geriatric population, and growing medical device industry.
- According to Our World in Data, the prevalence of cardiovascular diseases has surged from 6.9% in 1990 to 7.3% in 2021.
- According to data published by Our World in Data; the incidence rate of cardiovascular disorder was found to be 0.7%.
- According to an article published by British Heart Foundation, stroke is one of the biggest causes of death in UK causing around 34, 000 deaths each year.
- According to Australian Bureau of Statistics, 5.2% of population had heart, stroke, and vascular disease in 2022.
Industry Trends
- According to the article by Center of Disease Control and Prevention, in 2022 around 702, 880 people died from heart disease in U.S.
- According to the 2022 article by Center of Disease Control and Prevention heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups.
- According to 2022 article by World Health Organization, global geriatric population is expected to increase by 10% from 2015 to 2050.
- According to 2023 article by World Health Organization, cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year
Competitive Landscape
The major players operating in the clot management devices industry include as Medtronic, Boston Scientific Corporation, iVascular SLU, Teleflex Inc, Edwards Lifesciences Corporation, LeMaitre Vascular, Inc, Vascular Solutions, Inc, Straub Medical AG, Cook Medical, and Johnson & Johnson. Other players in the clot management devices market are Angio Dynamics, Inc, Bayer AG, and Stryker Corporation.
Recent Key Strategies and Developments
- In November 2021, Precision Medical Products announced the launch of its Circul8 Pro device, a powerful and portable take-home deep vein thrombosis (DVT) prevention product. With 20-plus-hour battery life, the Circul8 Pro is one of the market's longest-lasting portables, battery-operated compression devices.
- In April 2022 Penumbra, Inc., a global healthcare company focused on innovative therapies, announced that its Indigo Aspiration System with Lightning 7 and Lightning 12, designed for a single session blood clot removal in peripheral arterial and venous systems, including the treatment of pulmonary embolisms. The product secured the CE Mark and is now commercially available in Europe.
- In April 2022 Medtronic launched a registry for collecting real-world data associated with revascularization devices in acute ischemic stroke (AIS) patients. The Prospective Registry for Assessment of Acute Ischemic Stroke Patients Treated with Neuro thrombectomy Devices in India (PRAAN) is an industry-first endeavor to create a post-market registry to assess clinical outcomes associated with the use of Medtronic market-released revascularization devices in patients experiencing acute ischemic stroke. The duration of the registry is expected to be approximately 28 months, and up to 200 subjects are projected to be enrolled in it.
Key Benefits for Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the clot management devices market analysis from 2024 to 2033 to identify the prevailing clot management devices market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the clot management devices market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global clot management devices market trends, key players, market segments, application areas, and market growth strategies.
Clot Management Devices Market Report Highlights
| Aspects | Details |
 Market Size By 2033 | USD 3.2 Billion |
 Growth Rate | CAGR of 5.2% |
 Forecast period | 2024 - 2033 |
 Report Pages | 280 |
 By Product |
|
 By End User |
|
 By Region |
|
 Key Market Players | Johnson & Johnson, Boston Scientific Corporation, Cook Group, Lemaitre Vascular, Inc., Medtronic, Straub Medical AG, iVascular SLU, Edwards Lifesciences Corporation, Teleflex Incorporated, Vascular Solutions, Inc. |
The forecast period for Clot Management Devices Market is 2024-2033.
The global clot management devices market was valued at $1.9 billion in 2023
The base year is 2023 in Clot Management Devices Market
The market value of Clot Management Devices Market is projected to reach $3.2 billion by 2033
Major key players that operate in the Clot Management Devices Market are Medtronic, Boston Scientific Corporation, iVascular SLU, Teleflex Inc, Edwards Lifesciences Corporation
Loading Table Of Content...
